Stock CSMED CS MEDICA A/S
Add to a list
To use this feature you must be a member
Log inSign up

Other languages CS MEDICA A/S

Equities

CSMED

DK0061668225

End-of-day quote NORDIC GROWTH MARKET
Other stock markets
 23:00:00 23/06/2024 BST 		5-day change 1st Jan Change
4.923 DKK -3.25% Intraday chart for CS MEDICA A/S -3.03% +5.12%
06-17 CS Medica Completes Cannabidiol Medical Device Registration Process in Israel MT
06-12 CS Medica to Boost Denmark Operations With OneMed Partnership MT

Other languages

Search
See the results
Unlock all the news: Be the first to know and act before the market!
100% Free Registration
CS Medica Completes Cannabidiol Medical Device Registration Process in Israel
CS MEDICA Group erhält Zulassung seines kompletten Portfolios aus der CANNASEN® Produktreihe CBD-haltiger Therapien in Israel
CS MEDICA Group erhält Zulassung seines kompletten Portfolios aus der CANNASEN® Produktreihe CBD-haltiger Therapien in Israel
CS Medica to Boost Denmark Operations With OneMed Partnership
CS MEDICA Announces Strategic Partnership with OneMed
CS Medica, GP Europe Sign Letter of Intent for Potential Hemp Products Partnership
CS Medica A/S Announces Strategic Expansion Through Innovation and Collaboration
CS Medica Advances Spin-off, Listing Plans in Germany for Cannordic Unit
CS MEDICA A/S plant Ausgliederung und Börsengang von CANNORDIC A/S
CS MEDICA A/S plant Ausgliederung und Börsengang von CANNORDIC A/S
CS Medica A/S agreed to Spin-Off Cannordic A/S.
CS Medica A/S Reports Earnings Results for the Second Quarter and Six Months Ended March 31, 2024
CS Medica A/S Enters New Partnership with OTC Company Holding A Strong Position in the Chronic Pain Segment in Germany
CS Medica A/S Advances Global Reach with 180° Drug Store Alliance, Powered by Pull Market Strategy
CS Medica A/S Breaks Through Asian Market Barrier with Approval of Protective Nasal Gel in Malaysia
CS MEDICA A/S Partners with New Distributor to Launch CANNASEN into Jordan
CS Medica Set to Launch Pain Patch, Cosmetic Products in Australia
CS Medica A/S Announces FDA Authorization for Commercialization for Eight Products in the U.S. Market
CS Medica A/S Announces Financial Year Change
CS Medica A/S Reports Earnings Results for the Fourth Quarter Ended September 30, 2023
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. CSMED Stock
  4. News CS MEDICA A/S
  5. Other languages